In depth mass spectrometry based proteomic approach to explore the effect of curcumin in IL17A mediated alveolar barrier injury

S. Shaikh (Mangalore, India), Y. P Bhandary (Mangalore, India), M. Altaf Najar (Mangalore, India), A. Prabhu (Mangalore, India), T. Prasad (Mangalore, India), M. M Gouda (Mangalore, India), I. K (Mangalore, India), P. K Modi (Mangalore, India), Y. P Bhandary (Mangalore, India)

Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Session: Translational aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 3383
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Shaikh (Mangalore, India), Y. P Bhandary (Mangalore, India), M. Altaf Najar (Mangalore, India), A. Prabhu (Mangalore, India), T. Prasad (Mangalore, India), M. M Gouda (Mangalore, India), I. K (Mangalore, India), P. K Modi (Mangalore, India), Y. P Bhandary (Mangalore, India). In depth mass spectrometry based proteomic approach to explore the effect of curcumin in IL17A mediated alveolar barrier injury. 3383

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Development of mass spectrometry approaches to quantifying lipid mediators in airway disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011

Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis
Source: Eur Respir J 2013; 41: 1331-1339
Year: 2013



Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008


Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017

Proteomic profiling to define synergistic responses mediated by IL-17 and TNFa in the lungs
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions
Source: Eur Respir J 2008; 32: 1146-1157
Year: 2008



iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

Feasibility study using shotgun sequencing for proteomic analysis of human bronchoalveolar lavage applying HPLC coupled with linear ion trap MS/MS
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005

Effects of IL8 on epithelial cell activation: a proteomic approach
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

The inhibitory effect of fenretinide on the expression of inflammatory cytokines, possible molecular target of the drug and its relevance to cystic fibrosis.
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015


The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

A lung-on-chip in vitro approach to study inflammation at the alveolar level
Source: International Congress 2019 – Understanding lung disease: novel in vitro models
Year: 2019



A new possibility of process monitoring in lung cancer: Volatile organic compounds detected with ion mobility spectrometry to follow the success of the therapeutic process
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Quantitative proteomics study reveals cross-talk between autophagy and inflammation induced by cigarette smoke in airway
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011


Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011


LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018

Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012



Laser-capture microdissection, mass spectrometry and immunohistochemistry reveal pathological alterations in the extracellular matrix of transplanted lungs
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018